Current role of liquid biopsy in metastatic breast cancer and future perspectives

被引：0

作者：

Polasik, Arkadius ^{[1
]}

Friedl, Thomas W. P. ^{[1
]}

Schramm, Amelie ^{[1
]}

Schochter, Fabienne ^{[1
]}

Huober, Jens ^{[1
]}

Rack, Brigitte ^{[2
]}

Trapp, Elisabeth ^{[2
]}

Tzschaschel, Marie ^{[2
]}

Fasching, Peter A. ^{[3
]}

Taran, Florin-Andrei ^{[4
]}

Hartkopf, Andreas ^{[4
]}

Schneeweiss, Andreas ^{[5
,6
]}

Mueller, Volkmar ^{[7
]}

Aktas, Bahriye ^{[8
]}

Pantel, Klaus ^{[9
]}

Janni, Wolfgang ^{[1
]}

Fehm, Tanja ^{[10
]}

机构：

[1] Univ Hosp Ulm, Gynecol & Obstet, Prittwitzstr 43, D-89075 Ulm, Germany

[2] Klinikum Ludwig Maximilians Univ, Gynecol & Obstet, Munich, Germany

[3] Univ Hosp Erlangen, Gynecol & Obstet, Erlangen, Germany

[4] Univ Hosp Tubingen, Gynecol & Obstet, Tubingen, Germany

[5] Univ Hosp Heidelberg, Natl Ctr Tumor Dis, Heidelberg, Germany

[6] Univ Hosp Heidelberg, Dept Gynecol & Obstet, Heidelberg, Germany

[7] Univ Hosp Hamburg Eppendorf, Gynecol & Obstet, Hamburg, Germany

[8] Univ Hosp Essen, Gynecol & Obstet, Essen, Germany

[9] Univ Hosp Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany

[10] Heinrich Heine Univ, Gynecol & Obstet, Dusseldorf, Germany

来源：

GYNAKOLOGE | 2016年 / 49卷 / 09期

关键词：

Survival; Quality of life; Biopsy; Circulating tumor cells; Disease progression;

D O I：

10.1007/s00129-016-3929-7

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

The possibility of tumor dissemination via the blood systemhas been known for many years. Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) are detectable in the peripheral blood of patients with early as well as metastatic breast cancer. The prognostic relevance of these biomarkers has already been described. Repeated blood sampling along the course of disease enables CTCs and ctDNA to be monitored in terms of a regular "liquid biopsy". Combined with an additional molecular analysis, this might be helpful in gaining information about tumor characteristics, tumor heterogeneity, and possible therapy resistance based on these factors, without the necessity of an invasive core biopsy. The assessment of molecular attributesmay be indispensable for obtaining an optimized and personalized therapy aimed at extended survival and/or improved quality of life. This review summarizes current knowledge and describes possible future perspectives for the treatment of metastasized breast cancer.

引用

页码：680 / 684

页数：5

共 50 条

[41] The Present and Future of Clinical Management in Metastatic Breast Cancer [J].

Lin, Pauline H. ;

Laliotis, George .

JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)

[42] Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches [J].

Geurts, Veerle ;

Kok, Marleen .

CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (06) :628-643

[43] Current status and future perspectives of the managements of metastatic hormone-sensitive prostate cancer [J].

Matsumura, Naoki ;

Fujita, Kazutoshi ;

Nishimoto, Mitsuhisa ;

Minami, Takafumi ;

Tahara, Hideo ;

Yoshimura, Kazuhiro ;

Uemura, Hirotsugu .

WORLD JOURNAL OF UROLOGY, 2023, 41 (08) :2063-2068

[44] Perspectives of the Application of Liquid Biopsy in Colorectal Cancer [J].

Ding, Yuhan ;

Li, Wenxia ;

Wang, Kun ;

Xu, Chang ;

Hao, Mengdi ;

Ding, Lei .

BIOMED RESEARCH INTERNATIONAL, 2020, 2020

[45] Treatment of triple negative breast cancer (TNBC): current options and future perspectives [J].

De Laurentiis, M. ;

Cianniello, D. ;

Caputo, R. ;

Stanzione, B. ;

Arpino, G. ;

Cinieri, S. ;

Lorusso, V. ;

De Placido, S. .

CANCER TREATMENT REVIEWS, 2010, 36 :S80-S86

[46] Current and future opportunities for liquid biopsy of circulating biomarkers to aid in early cancer detection [J].

Gawel, Susan H. ;

Jackson, Laurel ;

Jeanblanc, Nicolette ;

Davis, Gerard J. .

JOURNAL OF CANCER METASTASIS AND TREATMENT, 2022, 8

[47] Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer [J].

Hench, Ivana Bratic ;

Hench, Jurgen ;

Tolnay, Markus .

FRONTIERS IN MEDICINE, 2018, 5

[48] Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer [J].

Aguiar de Freitas, Ana Julia ;

Causin, Rhafaela Lima ;

Varuzza, Muriele Bertagna ;

Calfa, Stephanie ;

Trovo Hidalgo Filho, Cassio Murilo ;

Komoto, Tatiana Takahasi ;

Souza, Cristiano de Padua ;

Chiquitelli Marques, Marcia Maria .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)

[49] Liquid Biopsy in Metastasized Breast Cancer as Basis for Treatment Decisions [J].

Krawczyk, Natalia ;

Fehm, Tanja ;

Banys-Paluchowski, Malgorzata ;

Janni, Wolfgang ;

Schramm, Annelle .

ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (03) :112-116

[50] Omission of sentinel node biopsy for breast cancer: Historical context and future perspectives on a modern controversy [J].

Jatoi, Ismail ;

Kunkler, Ian H. .

CANCER, 2021, 127 (23) :4376-4383

← 1 2 3 4 5 →